[Erythropoietin-induced hypertension].
Ioka
Takashi
T
Department of Nephrology, Jichi Medical School.
Kusano
Eiji
E
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001810:Blood Volume; D003937:Diagnosis, Differential; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D007676:Kidney Failure, Chronic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D012307:Risk Factors; D014655:Vascular Resistance
D000959:Antihypertensive Agents; D010975:Platelet Aggregation Inhibitors; D004921:Erythropoietin